OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genetic pathways to melanoma tumorigenesis
Mahmoud R. Hussein
Journal of Clinical Pathology (2004) Vol. 57, Iss. 8, pp. 797-801
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Melanoma, a Tumor Based on a Mutant Stem Cell?
James M. Grichnik, James A. Burch, Ryan D. Schulteis, et al.
Journal of Investigative Dermatology (2005) Vol. 126, Iss. 1, pp. 142-153
Open Access | Times Cited: 192

Skin metastasis: a pathologist's perspective
Mahmoud R. Hussein
Journal of Cutaneous Pathology (2009) Vol. 37, Iss. 9
Closed Access | Times Cited: 176

Deficient mismatch repair: Read all about it (Review)
Susan D. Richman
International Journal of Oncology (2015) Vol. 47, Iss. 4, pp. 1189-1202
Open Access | Times Cited: 174

Bortezomib/proteasome inhibitor triggers both apoptosis and autophagy-dependent pathways in melanoma cells
Denis Selimović, Benjamin B.O.W. Porzig, Abdelouahid El‐Khattouti, et al.
Cellular Signalling (2012) Vol. 25, Iss. 1, pp. 308-318
Closed Access | Times Cited: 140

Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
Mónica Bernal, Francisco Ruiz‐Cabello, Ángel Concha, et al.
Cancer Immunology Immunotherapy (2012) Vol. 61, Iss. 9, pp. 1359-1371
Closed Access | Times Cited: 107

M1 and M2 macrophages’ clinicopathological significance in cutaneous melanoma
Monica Falleni, Federica Savi, Delfina Tosi, et al.
Melanoma Research (2017) Vol. 27, Iss. 3, pp. 200-210
Closed Access | Times Cited: 97

Aberrant Expression of Collagen Triple Helix Repeat Containing 1 in Human Solid Cancers
Liren Tang, Derek L. Dai, Mingwan Su, et al.
Clinical Cancer Research (2006) Vol. 12, Iss. 12, pp. 3716-3722
Closed Access | Times Cited: 152

Tumour‐associated macrophages and melanoma tumourigenesis: integrating the complexity
Mahmoud R. Hussein
International Journal of Experimental Pathology (2006) Vol. 87, Iss. 3, pp. 163-176
Open Access | Times Cited: 92

Extracutaneous Malignant Melanomas
Mahmoud R. Hussein
Cancer Investigation (2008) Vol. 26, Iss. 5, pp. 516-534
Closed Access | Times Cited: 80

Laser Capture Microdissection: Methods and Applications
Kristen DeCarlo, Andrew Emley, O.E. Dadzie, et al.
Methods in molecular biology (2011), pp. 1-15
Closed Access | Times Cited: 62

The immune-related role of beta-2-microglobulin in melanoma
Chuqiao Wang, Zeqi Wang, Teng‐Teng Yao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26

Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions
Mahmoud R. Hussein, Dalia Elsers, Sabah A. Fadel, et al.
Journal of Clinical Pathology (2006) Vol. 59, Iss. 3, pp. 316-324
Open Access | Times Cited: 76

Genetically Heterogeneous and Clonally Unrelated Metastases May Arise in Patients With Cutaneous Melanoma
Terrence M. Katona, Timothy D. Jones, Ming‐Sheng Wang, et al.
The American Journal of Surgical Pathology (2007) Vol. 31, Iss. 7, pp. 1029-1037
Closed Access | Times Cited: 67

Mutational status of naevus-associated melanomas
Danielle Shitara, Gemma Tell‐Martí, Célia Bádenas, et al.
British Journal of Dermatology (2015) Vol. 173, Iss. 3, pp. 671-680
Open Access | Times Cited: 41

Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.
Matthias Rastetter, Undraga Schagdarsurengin, Christoph Lahtz, et al.
PubMed (2007) Vol. 22, Iss. 9, pp. 1005-15
Closed Access | Times Cited: 55

Association between natural killer cells and regression in melanocytic lesions
Kristopher McKay, Page C. Moore, Bruce R. Smoller, et al.
Human Pathology (2011) Vol. 42, Iss. 12, pp. 1960-1964
Closed Access | Times Cited: 45

Current management of melanoma
Erik M. Dunki-Jacobs, Glenda G. Callender, Kelly M. McMasters
Current Problems in Surgery (2013) Vol. 50, Iss. 8, pp. 351-382
Closed Access | Times Cited: 43

Exploring major signaling cascades in melanomagenesis: a rationale route for targetted skin cancer therapy
Paola M. Dantonio, Marianne Klein, Maria Renata Valente Brandão Freire, et al.
Bioscience Reports (2018) Vol. 38, Iss. 5
Open Access | Times Cited: 34

Immuno-Expression of Human Melanoma Stem Cell Markers in Tissues at Different Stages of the Disease
Sharma Bk, Vinod Manglik, E. George Elias
Journal of Surgical Research (2010) Vol. 163, Iss. 1, pp. e11-e15
Closed Access | Times Cited: 41

Gene network analyses point to the importance of human tissue kallikreins in melanoma progression
Waleska K. Martins, Gustavo Henrique Esteves, Otávio Machado de Almeida, et al.
BMC Medical Genomics (2011) Vol. 4, Iss. 1
Open Access | Times Cited: 34

Molecularly targeted therapy for melanoma
Jürgen C. Becker, John M. Kirkwood, Sanjiv S. Agarwala, et al.
Cancer (2006) Vol. 107, Iss. 10, pp. 2317-2327
Closed Access | Times Cited: 47

Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight
Mahmoud R. Hussein
British Journal of Dermatology (2005) Vol. 153, Iss. 1, pp. 18-21
Closed Access | Times Cited: 44

Laser Capture Microdissection: Insights into Methods and Applications
Meera Mahalingam
Methods in molecular biology (2018), pp. 1-17
Closed Access | Times Cited: 26

Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7—challenging the concept of dysplastic nevi as precursor lesions?
Kristen DeCarlo, Shi Yang, Andrew Emley, et al.
Human Pathology (2010) Vol. 41, Iss. 6, pp. 886-894
Closed Access | Times Cited: 28

Page 1 - Next Page

Scroll to top